METASTATIC PROSTATE CARCINOMA
Clinical trials for METASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for tough prostate cancer hits roadblock
Disease control TerminatedThis study looked at adding a new drug, ribociclib, to standard hormone therapy (enzalutamide) for men with advanced prostate cancer that had spread and stopped responding to hormone treatment. The goal was to find a safe dose and see if the combination could lower PSA levels. Th…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New PET scan aims to spot hidden prostate cancer
Diagnosis TerminatedThis study tested a special PET scan using a new imaging agent called 68Ga-PSMA-11 to get clearer pictures of prostate cancer that has spread in the body. It involved 15 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to see if this scan…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 20, 2026 11:55 UTC
-
Can genetic testing help men with spread prostate cancer?
Knowledge-focused TerminatedThis study offered free genetic testing to nearly 800 men whose prostate cancer had spread. Researchers looked for inherited gene changes linked to cancer risk and asked participants about their thoughts on testing. The goal was to learn if this approach works and to share result…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 26, 2026 08:52 UTC